| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/10/2002 | WO2001043733A3 Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation |
| 05/10/2002 | WO2001043696A9 Implant device for implanting cell culture |
| 05/10/2002 | WO2001039725A3 Drug preparations |
| 05/10/2002 | WO2001036433A3 Synthetic lipid-a analogs and uses thereof |
| 05/10/2002 | WO2001034131A3 Combination chemotherapy |
| 05/10/2002 | WO2001034117A9 A method for chemoprevention of prostate cancer |
| 05/10/2002 | WO2001028522A3 Method for producing liposome preparation |
| 05/10/2002 | WO2001026629A3 Neutral-cationic lipid for nucleic acid and drug delivery |
| 05/10/2002 | WO2001005388A3 Use of a fatty derivative for the treatment of external secretiondisorders |
| 05/10/2002 | WO2001000246A3 Hydrogels derived from chitosan and poly(ethylene glycol) |
| 05/10/2002 | CA2428124A1 Expanded perborate salt, use, and method of production |
| 05/10/2002 | CA2428066A1 Non-aspirating transitional viscoelastics for use in surgery |
| 05/10/2002 | CA2427952A1 Dna expression vectors |
| 05/10/2002 | CA2427795A1 Sustained release device for treating conditions of the joint |
| 05/10/2002 | CA2427731A1 Gnrh analogues for treatment of urinary incontinence |
| 05/10/2002 | CA2427629A1 Gene regulation therapy involving ferritin |
| 05/10/2002 | CA2427613A1 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine |
| 05/10/2002 | CA2427537A1 Use of enzymes obtained from ciliates as medicaments for promoting digestion |
| 05/10/2002 | CA2427194A1 Method for short-term and long-term drug dosimetry |
| 05/10/2002 | CA2426992A1 Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses |
| 05/10/2002 | CA2426967A1 Delivery system for entrapping charged macromolecules and a method for preparing same |
| 05/10/2002 | CA2426200A1 Inhibition or reversal of skin aging by actin-sequestering peptides |
| 05/10/2002 | CA2426047A1 Therapeutic oligonucleotides of reduced toxicity |
| 05/10/2002 | CA2425627A1 Kahalalide f |
| 05/09/2002 | WO2002036591A2 Inhalative solution formulation containing a tiotropium salt |
| 05/09/2002 | US20020055769 Stent with smooth ends |
| 05/09/2002 | US20020055734 Ingestible device |
| 05/09/2002 | US20020055667 Absorbable brachytherapy and chemotherapy delivery devices and methods |
| 05/09/2002 | US20020055666 Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors |
| 05/09/2002 | US20020055629 Method for producing chitin or chitosan |
| 05/09/2002 | US20020055573 Stabilized monomer adhesive compositions |
| 05/09/2002 | US20020055542 E.g., phenylbutyric acid; for treating a subject having an ulcer or radiation fibrosis. |
| 05/09/2002 | US20020055540 Oral creatine supplement and method for making same |
| 05/09/2002 | US20020055531 Methods for treatment of inflammatory diseases |
| 05/09/2002 | US20020055512 Release rate controlling substance; treating metabolic syndrome, diabetes mellitis type II or symptoms |
| 05/09/2002 | US20020055503 Treatment of seizures resulting from, e.g. epileptic attack. |
| 05/09/2002 | US20020055496 Formulation and system for intra-oral delivery of pharmaceutical agents |
| 05/09/2002 | US20020055494 Combinations of formoterol and mometasone furoate for asthma |
| 05/09/2002 | US20020055486 Pharmaceutical composition for ophthalmic use |
| 05/09/2002 | US20020055481 DNA that represents the splicing enhancer sequence (SES) in exon 45 of human dystrophin gene, and serves as a template in preparation of the antisense oligonucleotide, which is used to induce exon 45 skipping |
| 05/09/2002 | US20020055477 Immunomodulatory formulations and methods for use thereof |
| 05/09/2002 | US20020055470 Administering a nucleoside analog such AZT or ganciclovir to prevent resistance of tumor cells to chemotherapeutic agents, methotrexate or radiotherapy |
| 05/09/2002 | US20020055464 Polyacid glycopeptide derivatives |
| 05/09/2002 | US20020055461 Stable polymer aqueous/aqueous emulsion system and uses thereof |
| 05/09/2002 | US20020055460 Adminstering a compound that binds to a receptor for the glucagon-like peptide-1 (GLP-1) |
| 05/09/2002 | US20020055033 Nanostructured deposition and devices |
| 05/09/2002 | US20020054915 Prolonged anesthesia in joints and body spaces |
| 05/09/2002 | US20020054914 Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein |
| 05/09/2002 | US20020054913 Stable drug from for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
| 05/09/2002 | US20020054912 Accelerating a stream comprising a liquid and vibrating the stream, to form particles which have a diameter that is smaller than the diameter of the nozzle used to form the stream and allowing the formation of micro and nanoparticles |
| 05/09/2002 | US20020054911 Novel oral dosage form for carvedilol |
| 05/09/2002 | US20020054910 A topical film-forming aqueous composition for covering a skin lesion, characterized in that it comprises a mixture of a polyvinyl alcohol and a chitosan and is capable of forming dry film in situ |
| 05/09/2002 | US20020054908 An oral pharmaceutical dosage from including a mixture of a delay release formulation of a non-steroidal anti-inflammatory drug and a mixture containing prostaglandin and one or more excipients |
| 05/09/2002 | US20020054907 Multiparticulate modified release composition |
| 05/09/2002 | US20020054906 Dry mix formulation for bisphosphonic acids |
| 05/09/2002 | US20020054905 A starch polysaccharide having a tap density of < 0.2 g/ml, when used in an binding in a tablet, prevents the crushing strength of tablet from decreasing more than 20% decrease in crushing strengh when exposed to 95% relative humidity |
| 05/09/2002 | US20020054904 Stable pergolide mesylate and process for making same |
| 05/09/2002 | US20020054903 Direct compression polymer tablet core |
| 05/09/2002 | US20020054902 Liposomes containing therapeutic genes are conjugated to targeting agents to provide transport of encapsulated gene across blood-retainal barrier and plasma membrane of ocular cell, where this gene expresses encoded therapeutical agent |
| 05/09/2002 | US20020054900 Barrier layer positioned over composite layer and being of thickness adequate to provide controlled release of bioactive agent, barrier layer being applied by low energy plasma polymerization |
| 05/09/2002 | US20020054899 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 05/09/2002 | US20020054896 Applying onto healed wound a composition comprising a fluid, film-forming carrier, and subsequently hardening the carrier into a tangible membrane juxtaposed to the healed wound thereby reducing scarring or improving the appearance thereof |
| 05/09/2002 | US20020054895 And at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water; skin protectants |
| 05/09/2002 | US20020054886 For treatment of disseminated candidiasis due to infection by C.albicans; monoclonal antibodies for use in passive immunization against candidal infections |
| 05/09/2002 | US20020054868 Bacterial strain, processes plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/09/2002 | US20020054867 A probiotic formulation of Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799); containing at least one volatile fraction (VF) of a plant extract |
| 05/09/2002 | US20020054866 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/09/2002 | US20020054859 A mixture of olive and parsley oils useful for treatment of halitosis or bad breath |
| 05/09/2002 | US20020054856 Nicotine mucosal spray |
| 05/08/2002 | EP1203614A1 Process and apparatus for preparing lipid vesicles |
| 05/08/2002 | EP1203590A1 Solid preparations containing chitosan powder and process for producing the same |
| 05/08/2002 | EP1203589A1 Use of terpene alcohol ethoxylates as solubilizers in cosmetic or pharmaceutical formulations or in concentrates for food compositions |
| 05/08/2002 | EP1203581A2 Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
| 05/08/2002 | EP1203580A1 Quickly disintegrating solid preparations |
| 05/08/2002 | EP1203531A2 Water soluble compositions containing chlorhexidine and their use |
| 05/08/2002 | EP1203084A1 Microencapsulated nitric oxide synthase source |
| 05/08/2002 | EP1203010A1 Antisense modulation of fadd expression |
| 05/08/2002 | EP1203004A1 HIGH AFFINITY TGF$g(g) NUCLEIC ACID LIGANDS AND INHIBITORS |
| 05/08/2002 | EP1203002A1 Process for preparing a charcoal-gm1 complex |
| 05/08/2002 | EP1202996A1 Titanium derived compounds, preparation and use thereof |
| 05/08/2002 | EP1202755A1 Cartilage or bone matrix as a nucleic acid delivery vehicle |
| 05/08/2002 | EP1202747A1 Sustained release drug dispersion delivery device |
| 05/08/2002 | EP1202745A1 Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them |
| 05/08/2002 | EP1202744A2 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 05/08/2002 | EP1202743A2 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 05/08/2002 | EP1202742A2 Method and apparatus for the recovery of non-solvent type fills from gelatin capsules |
| 05/08/2002 | EP1202739A1 Rapid immediate release oral dosage form |
| 05/08/2002 | EP1202723A2 Use of anti-muscarinic agents for treating skin disorders |
| 05/08/2002 | EP1202722A1 Uses compositions for treating or preventing sleep disturbances using very low doses of cyclobenzaprine |
| 05/08/2002 | EP1202719A1 Anesthetic composition for intravenous injection comprising propofol |
| 05/08/2002 | EP1202716A1 Rapidly dissolving dosage form and process for making same |
| 05/08/2002 | EP1202715A2 Quick-release extrudates, method for preparing the same and compositions obtained from said extrudates |
| 05/08/2002 | EP1202714A1 Vinyl ether lipids with cleavable hydrophilic headgroups |
| 05/08/2002 | EP1202713A2 Artificial tear replacement solution |
| 05/08/2002 | EP1202703A2 Oil-based cosmetics containing water-soluble actives |
| 05/08/2002 | EP1202700A1 Oil-in-water emulsion with improved stability |
| 05/08/2002 | EP1202691A2 Exothermic bandage |
| 05/08/2002 | EP1202670A1 Hollow microspheres with controlled fragility for medical use |
| 05/08/2002 | EP1202639A2 Methods for suppressing appetite and enhancing exercise and recovery |
| 05/08/2002 | EP1202620A1 Anti-inflammatory therapy for inflammatory mediated infection |